Fecal microbiota transplantation for gastrointestinal disorders

Thomas Malikowski, Sahil Khanna, Darrell S. Pardi

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Purpose of review: The importance of the gut microbiome in human health is being increasingly recognized. The purpose of this review is to examine the existing literature pertaining to alterations in the gut microbiome and the utility of microbiome restoration therapies in gastrointestinal disorders. Recent findings: Imbalance and maladaptation of the microbiome, termed dysbiosis, has been associated with several disease states such as irritable bowel syndrome, Clostridium difficile infection, inflammatory bowel diseases, nonalcoholic fatty liver disease, and obesity among others. The possibility of restoration of normal microbiota has become an attractive concept for diseases in which the normal microbiome is perturbed. The rationale of using fecal microbiota transplantation to treat disease has been validated by its successful use in treating recurrent Clostridium difficile infection, which occurs as a result of decreased microbial diversity in the gut, most often in the setting of recent antibiotic treatment. Similar strategies may be applicable to other disorders. Summary: Alterations in the gut microbiome are associated with several disorders, and microbiome restoration based therapies such as fecal microbiota transplantation may be an adjunct to conventional treatments but more investigation is needed.

Original languageEnglish (US)
Pages (from-to)8-13
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume33
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Microbiota
Clostridium Infections
Clostridium difficile
Dysbiosis
Irritable Bowel Syndrome
Therapeutics
Inflammatory Bowel Diseases
Obesity
Fecal Microbiota Transplantation
Anti-Bacterial Agents
Health
Gastrointestinal Microbiome

Keywords

  • Fecal microbiota transplantation
  • Inflammatory bowel disease
  • Irritable bowel syndrome
  • Microbiome

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Fecal microbiota transplantation for gastrointestinal disorders. / Malikowski, Thomas; Khanna, Sahil; Pardi, Darrell S.

In: Current Opinion in Gastroenterology, Vol. 33, No. 1, 2017, p. 8-13.

Research output: Contribution to journalReview article

Malikowski, Thomas ; Khanna, Sahil ; Pardi, Darrell S. / Fecal microbiota transplantation for gastrointestinal disorders. In: Current Opinion in Gastroenterology. 2017 ; Vol. 33, No. 1. pp. 8-13.
@article{81add4b0c9db461d8daee993108b4f0c,
title = "Fecal microbiota transplantation for gastrointestinal disorders",
abstract = "Purpose of review: The importance of the gut microbiome in human health is being increasingly recognized. The purpose of this review is to examine the existing literature pertaining to alterations in the gut microbiome and the utility of microbiome restoration therapies in gastrointestinal disorders. Recent findings: Imbalance and maladaptation of the microbiome, termed dysbiosis, has been associated with several disease states such as irritable bowel syndrome, Clostridium difficile infection, inflammatory bowel diseases, nonalcoholic fatty liver disease, and obesity among others. The possibility of restoration of normal microbiota has become an attractive concept for diseases in which the normal microbiome is perturbed. The rationale of using fecal microbiota transplantation to treat disease has been validated by its successful use in treating recurrent Clostridium difficile infection, which occurs as a result of decreased microbial diversity in the gut, most often in the setting of recent antibiotic treatment. Similar strategies may be applicable to other disorders. Summary: Alterations in the gut microbiome are associated with several disorders, and microbiome restoration based therapies such as fecal microbiota transplantation may be an adjunct to conventional treatments but more investigation is needed.",
keywords = "Fecal microbiota transplantation, Inflammatory bowel disease, Irritable bowel syndrome, Microbiome",
author = "Thomas Malikowski and Sahil Khanna and Pardi, {Darrell S.}",
year = "2017",
doi = "10.1097/MOG.0000000000000326",
language = "English (US)",
volume = "33",
pages = "8--13",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Fecal microbiota transplantation for gastrointestinal disorders

AU - Malikowski, Thomas

AU - Khanna, Sahil

AU - Pardi, Darrell S.

PY - 2017

Y1 - 2017

N2 - Purpose of review: The importance of the gut microbiome in human health is being increasingly recognized. The purpose of this review is to examine the existing literature pertaining to alterations in the gut microbiome and the utility of microbiome restoration therapies in gastrointestinal disorders. Recent findings: Imbalance and maladaptation of the microbiome, termed dysbiosis, has been associated with several disease states such as irritable bowel syndrome, Clostridium difficile infection, inflammatory bowel diseases, nonalcoholic fatty liver disease, and obesity among others. The possibility of restoration of normal microbiota has become an attractive concept for diseases in which the normal microbiome is perturbed. The rationale of using fecal microbiota transplantation to treat disease has been validated by its successful use in treating recurrent Clostridium difficile infection, which occurs as a result of decreased microbial diversity in the gut, most often in the setting of recent antibiotic treatment. Similar strategies may be applicable to other disorders. Summary: Alterations in the gut microbiome are associated with several disorders, and microbiome restoration based therapies such as fecal microbiota transplantation may be an adjunct to conventional treatments but more investigation is needed.

AB - Purpose of review: The importance of the gut microbiome in human health is being increasingly recognized. The purpose of this review is to examine the existing literature pertaining to alterations in the gut microbiome and the utility of microbiome restoration therapies in gastrointestinal disorders. Recent findings: Imbalance and maladaptation of the microbiome, termed dysbiosis, has been associated with several disease states such as irritable bowel syndrome, Clostridium difficile infection, inflammatory bowel diseases, nonalcoholic fatty liver disease, and obesity among others. The possibility of restoration of normal microbiota has become an attractive concept for diseases in which the normal microbiome is perturbed. The rationale of using fecal microbiota transplantation to treat disease has been validated by its successful use in treating recurrent Clostridium difficile infection, which occurs as a result of decreased microbial diversity in the gut, most often in the setting of recent antibiotic treatment. Similar strategies may be applicable to other disorders. Summary: Alterations in the gut microbiome are associated with several disorders, and microbiome restoration based therapies such as fecal microbiota transplantation may be an adjunct to conventional treatments but more investigation is needed.

KW - Fecal microbiota transplantation

KW - Inflammatory bowel disease

KW - Irritable bowel syndrome

KW - Microbiome

UR - http://www.scopus.com/inward/record.url?scp=85007507946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007507946&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000326

DO - 10.1097/MOG.0000000000000326

M3 - Review article

C2 - 28134687

AN - SCOPUS:85007507946

VL - 33

SP - 8

EP - 13

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 1

ER -